It also affects tumor metabolism through the β-cateinin/c-myc signaling pathway, including inhibiting the protein expression of GLUT, HK2, PKM2, LDHA and other glycolysis-related proteins, and promoting glutaminolysis (Sharma et al., 2017). Here, MYC is linked to neoplasm.